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Abstract  
PVA coated and fluorescent dye (Cy3.5) functionalized vinyl alcohol/vinyl amine copolymer coated 
superparamagnetic iron oxide nanoparticles (SPION) were evaluated for systemic distribution and elimination 
after intraarticular injection in sheep. Observation was done at 3, 24, 72 and 120 hours after injection using 
light microscopy, fluorescent microscopy and confocal microscopy. No pathologic influence of SPION on the 
tissue harvested could be seen. A significantly increased iron content could be identified in the kidneys, lymph 
nodes and spleen after injection of SPION. No particles were detected in the liver, the urinary and the gall 
bladder. No positive fluorescent signal could be attributed to SPION throughout the organs. Our results 
indicated that the iron component of the SPION is possible to be incorporated into the physiologic iron 
metabolism after reabsorption in the proximal tubule system of the kidney and that concentration levels of 
Cy3.5 are too low to be detected throughout the body. 
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Introduction 
Nanoparticles have recently received much attention due to their characteristics that enable them to serve as 
drug carriers for targeted drug delivery [1, 2]. Several types and sizes of particles can be used to deliver 
pharmaceutical products, plasmids or peptides locally to specific organs. Among those particles, the 
superparamagnetic iron oxide particles (SPION) are especially attractive because of their potential to be 
locally concentrated and to be held in place by external magnets, enhancing the uptake of the delivered 
molecule at the site of interest. 
In modern clinical medicine, SPION are used for diagnostic purposes in MRI and in experimental cancer 
therapy [3-7]. In recent studies these types of particles were used to diagnose macrophage activity within the 
joint capsule in experimental rats [8]. The application of SPION as magnetic drug carriers into diarthrodial 
joints is also limited to experimental studies. Since the magnetic properties of these particles make them an 
attractive tool to treat joint inflammations and/or modulate articular cartilage degradation, our group 
investigated whether SPION coated with poly(vinyl alcohol) (PVA) could be used for intraarticular application 
in the carpometaphalangeal and in stifle joints of experimental sheep [9]. In this study, PVA-SPION of a 6-10 
nm core and overall diameter of 30-40 nm proved to be biocompatible. They were successfully taken up by 
synoviocytes of the synovial membrane and were distributed within the connective tissue of the joint capsule. 
In the course of the five day evaluation period PVA-SPION showed a peak concentration in the synovial 
membrane at 120 hours after intraarticular application.   
It is generally accepted that after systemic administration, SPION are eliminated from the body through the 
reticuloendothelial system [10]. Nanoparticles were mainly detected in the liver and the spleen [11]. It was 
hypothesized that nanoparticles were degraded and that iron was further incorporated into hemoglobin and 
thus was introduced into the physiologic metabolism of Fe3+/Fe2+ ions of the body. However, the systemic 
elimination of SPION from the joint space has not been previously reported.  
Therefore, the goal of our study was to investigate the systemic distribution and elimination of plain PVA-
SPION and of Cy3.5 functionalized vinyl alcohol/vinyl amine copolymer-SPION after intraarticular 
application in sheep. Our hypothesis was based on the assumption that particles would be phagocytosed by 
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macrophage-like cells in the joint tissue, subsequently be transported via lymph nodes and the lymphatic 
system and finally after introduction into systemic circulation distributed to the spleen and the liver.  
This evaluation was part of our earlier study, where the biocompatibility and intracellular uptake of the same 
particles has been tested in the joint tissue [9]. Tissue samples of the sheep have been harvested at the time of 
sacrifice and served as basis for this investigation. 
 
Materials and methods 
SPION: Plain PVA-coated SPION and amino-PVA-coated with Cy3.5 functionalized SPION were used for the 
study.  
Cy3.5 labeled vinyl alcohol/vinyl amine copolymer coated SPION and poly(vinyl alcohol) coated SPION were 
investigated in this study. The compounds will be referred to as amino-PVA-Cy3.5-SPION and PVA-SPION, 
respectively.  
Preparation of nanoparticles: The preparation of superparamagnetic iron oxide nanoparticles and the vinyl 
amine /vinyl alcohol co-polymer followed a standard protocol and is described elsewhere [12, 13] . Briefly, 
iron oxide polymer coated nanoparticles were prepared by alkaline co-precipitation of ferric and ferrous 
chlorides in aqueous solution. Solutions of FeCl3·6H2O (0.086 M) and FeCl2·4H2O (0.043 M) were mixed and 
precipitated with concentrated ammonia while stirring vigorously. The black precipitate was washed several 
times with ultra-pure water until the pH decreased from 10 to 7. The solid was collected and refluxed in a 
mixture of 0.8 M nitric acid and 0.21 M aqueous Fe(NO3)3·9H2O for 1 h. The system was allowed to cool to 
room temperature, the remaining liquid was discarded, and 100 ml of ultra-pure water was added to the slurry, 
which immediately dispersed. The brown suspension was dialysed for 2 days against 0.01 M nitric acid, and 
stored at 4 °C. In a final step the obtained product was mixed with the different polymer solutions to obtain 
either SPION coated with polyvinyl alcohol (Mowiol® 3-83), or SPION coated with vinyl alcohol/vinyl amine 
copolymer (M12, Erkol S.A.). Here, vinyl amine/vinyl alcohol co-polymer coated SPIONs were diluted in 25 
mM carbonate buffer (pH=9.3) to a final concentration of 2.5 mg Iron/ml dispersion. The used Cy3.5 dye 
(Amersham Biosciences) is a monofunctional NHS-Ester, and was provided in a dried, premeasured form 
ready for the labeling of compounds containing free amino groups. The dispersion of polymer coated SPIONs 
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was added to the dye vial and thoroughly mixed. The particles were incubated for 1 hour and the labeled 
particles were separated from excess, unconjugated dye using disposable PD-10 desalting columns (Amersham 
Biosciences). The column was pre-equilibrated with 25 mM phosphate buffer, which was also used to elute the 
particles. The concentration of the dye per particle was determined by photometrical quantification of the iron 
and the dye using a molar extinction coefficient of 150’000 M-1cm-1 at 581nm for the Cy3.5. 
Experimental animals: Fourteen (14) Swiss Alpine sheep 2 - 4 years of age were selected for the study. The 
general health of sheep was determined and the sheep were routine dewormed and vaccinated prior to the 
study. During a 2 weeks adaptation period before the start and until the end of the project, the animals were 
kept in groups in box stalls. They were fed grass hay and had free access to water, except 24 hours prior to 
anesthesia when all food was removed.   
The sheep were divided into four groups, A to D. Each group consisted of four animals, of which two animals 
received plain PVA-SPION and the other two animals received amino-PVA-Cy3.5-SPION into their joints. 
Group A consisted of two animals which received plain PVA-SPION and were sacrificed 3 hours after 
surgery. Sheep of group B, C and D were sacrificed after 24, 72 and 120 hours, respectively after SPION 
application.  Six additional sheep, slaughtered for reasons other than infectious or systemic diseases served as 
control animals. 
Joint injections: To perform the joint injections, the sheep were placed under general anesthesia.  The animals 
were sedated with medetomidine (5 µg/kg bwt i.m., Domitor, Orion-Farmos, Turku, Finland) before 
induction using diazepam (0.01 mg/kg bwt i.v., Valium, Roche, Basel, Switzerland) and ketamine (20 mg/kg 
bwt i.v., Narketan, Chassot AG, Bern, Switzerland).  Anesthesia was maintained with isoflurane (Forene, 
Abbott AG Baar, Switzerland) in 100% oxygen.  Analgesia was accomplished by intravenous injections of 
buprenophine (0.03 ml/kg bwt. Temgesic, ESSEX Chemie AG, Luzern, Switzerland) perioperatively and 
postoperatively every 4 hours as needed.  
The skin at the area of the joints to be injected was clipped and prepared in a routine surgical manner. Proper 
placement of the needle in the joint cavity was confirmed by aspiration of synovial fluid. 1.0 ml of the 
nanoparticle suspension was injected into each carpometaphalangeal joint and 2.0 ml into the lateral pouch of 
the femorotibial joint. 
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Evaluation: Macroscopic evaluation was done at the time of sacrifice, where liver, spleen, kidneys, urinary 
bladder, gall bladder, inguinal and axillary lymph nodes were collected from all animals apart from the joint 
tissues. Results of the joint tissues were reported elsewhere [9]. Tissue samples of these organs were taken and 
processed for standard paraffin histology. Slides of the paraffin blocks were stained with Haematoxylin-Eosin 
(H.E.), Pearl’s Prussian blue (Fe3+) and Turnbull (Fe2+). 
Histological evaluation for pathologic changes and presence of nanoparticles in the tissue samples was 
performed using light microscopy (DMR, Leica, Glattbrugg, Switzerland) and digital imaging (DC 200, 
Leica). Fluorescence was evaluated on native slides with the same microscope, equipped with an I3 filter with 
excitation range of 450-490nm. 
Confocal microscopy was performed for better evaluation of SPION distribution using CLSM (confocal laser 
scanning microscopy, Leica TCS SP2 AOBS, Leica Microsystems, Mannheim, Germany). The IMARIS 
software (Bitplane AG, Zurich, Switzerland) was used for 2-D multi-channel image processing. Background 
fluorescence of cells was determined by analyzing untreated tissues. 
H.E. stained slides were used for assessment of morphologic changes in tissue samples.  Detection of 
nanoparticles was done using Fe2+ and Fe3+ stained slides. A scoring system was developed to assess 
nanoparticle concentration ranging from 0 - 3, with score 0 = no nanoparticles, score 1= nanoparticles 
observed in up to 33% of the field of view, score 2= nanoparticles observed in 34 – 66% of the field of view, 
and 3= nanoparticles observed in 67-100% of the field of view.  On each slide, six power fields on a 20-fold 
magnification were judged so a total score of maximally 18 per slide was possible. Fluorescence was 
compared between groups, but also within groups to assess whether it was similar to particle distribution (Fe3+, 
Fe2+). 
Statistics: One factorial variance analysis for the incubation time was calculated for each organ in which 
SPION, not divided into PVA-SPION or amino-PVA-Cy3.5-SPION, were found at 0 hours, reflecting control 
animals, 3 hours, 24 hours, 72 hours and 120 hours.  Independence between the different results at each time 
could be assumed since data of different animals were available at each time evaluated. The Bonferroni/Dunn 
procedure was used to analyse variances at different times. P-values of 0.05 or less were considered 
significant. 
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Results 
Identical distribution of the PVA-SPION and amino-PVA-Cy3.5-SPION was found within groups irrespective 
of the Fe3+/Fe2+ special stains used. Therefore, only scores of particle distribution will be discussed in the 
following.  
Kidney: None of the slides showed any signs of histopathologic changes as viewed with the H.E. stained 
specimens. Tissue samples of 2 out of 6 control and 9 of the 14 injected animals showed positive reaction after 
P.B. (Fe3+) staining. Exclusively affected were the epithelial cells of the proximal tubules (Fig.1a). The 
cytoplasm was colored light blue, with or without dark blue granules intracellularly.   
Semiquantitative evaluation at 3, 24, 72 and 120 hours after joint injection, indicated a significant increase in 
Fe3+ ions in animals that had received SPION. ANOVA calculations of the observations made in the kidneys 
resulted in F- values of 13.29 with a significance level of less than 0.0001, indicating that there was a 
significant increase in Fe3+ ions in the experimental animals when compared to the control animals at all time 
points of the study. No other significant differences were shown with Bonferroni/Dunn calculations. This 
observation indicated a quick increase of Fe3+ ions as early as 3 hours post-injection after which the 
concentration stayed on the same level throughout the experimental period. (Fig. 1b) 
In Turnbull stained tissue samples Fe2+ ions were detected in epithelial cells of the proximal tubules only in 
two animals, one in the 24-hours group and one in the 72-hours group (Fig. 1c). This resulted in a mean value 
of 0.021 for the 24-hours group and 0.125 for the 72-hours group in the 0-3 scoring system. Bonferroni/Dunn 
calculations demonstrated a significant elevation of the 72-hours group compared to all other groups in the 
study (P= 0.0024) (Fig. 1d).   
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Lymph nodes: Both inguinal and axillary lymph nodes were harvested from all animals in this study. 
Histological changes seen in most of the tissue samples of both control and injected animals included reactive 
lymphoid or  hyperplasia with plasma cells, a mildly increased number of macrophages (sinus histiocytosis), 
neutrophilic and eosinophilic granulocytes as well as some “Russell bodies”. No differences were noted 
between injected and control animals and the described changes were not interpreted to be significant in any of 
the sheep. 
After P.B. staining tissue samples of 2 out of 6 control animals, and of all injected sheep showed bluish stained 
macrophages in at least one lymph node. Although blue stained macrophages were found in injected animals 
as well as in control sheep, the quantity of stained cells increased significantly as from 3 hours after SPION 
joint injections and remained elevated until 120 hours post injection. ANOVA calculation was done for both 
left and right axillary and inguinal lymph nodes combined, which resulted in an F-value of 19.68. This 
corresponds to a significance level of less than 0.0001. A differentiated examination demonstrated significant 
elevations of counts when compared to control animals 3, 24, 72 and 120 hours after injection. The highest 
level of counts was reached at 72 hours post injection (increase 3 hours/72 hours p= 0.0024; increase 24 hours/ 
72 hours p= 0.0003). No other significant change was observed during the test period. (Fig. 2) 
In the Turnbull stained samples, Fe2+ ions in macrophages of both axillary lymph nodes in one sheep of the 24-
hours group and both inguinal lymph nodes in one sheep of the 120-hours group were found. ANOVA 
calculations resulted in mean values of 0.177 for the 24-hours group and 0.100 for the 120-hours group on our 
0-3 scoring system. This demonstrates a significant elevation of Fe2+ ions 24 hours post injection compared to 
the control animal, the 3-hours and the 72-hours groups when differentiated after Bonferroni/Dunn analysis. 
(Fig. 3) 
Spleen: With the exception of one control sheep, spleen samples of all animals in this study were examined 
histologically. Several of the H.E. stained specimen demonstrated reactive hyperplasia with an increased 
number of macrophages and plasma cells.  None of the changes we saw on H.E. stained slides were interpreted 
as outside the normal variations in sheep of this age group. 
Blue colored macrophages were seen in P.B. stained samples of all animals. The white splenic pulp was 
always free of positively stained cells. The red pulp contained large amounts of blue stained macrophages, to a 
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degree where the spleen was diagnosed with moderate hemosiderosis in 11 out of 14 injected animals (Fig. 
4a). ANOVA calculation for the spleen showed a P- value of 36.20 with a significance level of less than 
0.0001. A large amount of stained Fe3+ molecules were found in control animals, but the Bonferroni/Dunn 
calculations demonstrated significant elevations for injected animals with P-values of less than 0.0001 at all 
times measured. Statistical evaluation showed a continuous increase of values with the time. The differences 
between 24 hours and 120 hours (p< 0.0001) and between 72 hours and 120 hours (p= 0.0017) were 
significant. Comparable interpretation of the results from 3 hours post injection sheep required caution since 
results of only 2 animals of this group were available. (Fig. 4b) 
In the Turnbull stained specimen, macrophages in 3 of the 6 control animals and 12 out of 14 injected animals 
were stained positive (Fig. 4c). The mean scores for Fe2+ ions were all lower than for the Fe3+ ions detected 
with the P.B. staining. ANOVA calculations for Fe2+ ions on spleen samples demonstrated a significant 
increase of stained particles between animals in the 24-hours and 72-hours groups when compared to control 
animals. The counts on slides of the 120-hours group were significantly higher than in all other groups in this 
study. (Fig. 4d) 
Liver: Liver samples of all animals in this study were examined samples of three sheep visualized with H.E. 
stained slides showed mildly to moderately increased numbers of inflammatory cells (lymphocytes, 
plasmacells, macrophages, eosinophils) periportally indicating chronic parasitism confirmed at the time of 
sacrifice (fluke infestation). No alterations were noticed distinguishing treated from non-treated animals. 
After P.B. staining, no bluish stained cells were seen on specimen of either control or 3-hours group animals. 
Blue stained cells were seen in one of the sheep in the 24-hour group and a significantly increasing amount of 
blue stained cells with time during the course of the experiment. The affected cells were mainly Kupffer cells, 
but also periportal macrophages and rarely hepatocytes contained Fe3+ ions (Fig. 5a). Statistical calculation 
gave F- value for the liver as 29.49 and the P- value was <0.0001. Significant increases (p< 0.0001) were 
shown between the times 0h/72h, 0h/120h, 3h/120h, 24h/120h and 72h/120h. These results combined together 
show a constant increase of Fe3+ ions from 3 hours post- injection until the end of the test period (Fig. 5b).   
In the Turnbull stained samples, we also found stained Kupffer cells, macrophages and some hepatocytes. Fe2+ 
ions were seen in animals of all groups and in higher mean scores than the Fe2+ ions were seen in animals of 
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all groups and with a higher mean scores than the Fe3+ ions. Scores for the control animals and for the 24-
hours group were significantly lower than for the 3-hours, the 72-hours and the 120-hours groups (Fig. 5c). 
Urinary and gall bladder: Tissue samples of the gall bladder and the urinary bladder wall of all animals in the 
experiment were available for histologic examination. None of these two organs showed histopathologic 
changes on the H.E. stained specimen and no Fe3+ or Fe2+ ions were found using either P.B. or Turnbull 
staining, respectively. 
Fluorescence: In all organs and in all experimental animals evaluated, strong background fluorescence of the 
tissue was detected. Some fluorescence signal of amino-PVA-Cy3.5-SPION was detected; however, this could 
not be clearly and distinctively be attributed to either SPION or background. Therefore, no further histological 
nor statistical evaluation was performed. 
 
Discussion 
In this in vivo study, two different intraarticularly injected SPION were assessed for their physiological 
metabolism and potentially harming effects in different organs in sheep during a time period between 3 to 120 
hours after injection. Systemic distribution of particles in vivo could be followed for both, the plain PVA-
SPION as well as the amino-PVA-Cy3.5-SPION. After intraarticular injection into the carpometaphalangeal 
and stifle joints of the sheep, the iron component of SPION was distributed via the regional axillary and 
inguinal lymph nodes, respectively, the reticuloendothelial system. Based on iron stainings our results suggest 
that filtration through the glomerulonephritic system and reabsorption within the proximal tubules of the 
kidney. Thereafter, iron ions were taken up into the reticuloendothelial system ending up mainly in the spleen 
but also the liver. 
A clear and consistent statistically significant distribution of nanoparticles in different organs and over time 
could not always be established. This could be due to several reasons, among which the small number of 
animals per group could be the most important. Uneven particle distribution within the same organs was 
noticed and certainly this contributed to this phenomenon, although we tried to distribute the chances evenly 
by evaluation of 6 fields of view per slide for each animal and by evaluation of different tissue sections per 
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organ. Additionally, functionalization of PVA-SPION with Cy3.5 dye may have altered the rate of elimination 
when compared to the plain PVA-SPION.  
An experimental animal model with sheep was established to evaluate the future clinical use of magnetic 
targeted drugs. For costs and ethical reasons only a limited number of experimental animals was used. 
Therefore our goal was not to provide toxicological and safety data for the SPION used, but to proof the 
principle for magnetic drug targeting with SPION and to give a first idea about body distribution, possible 
toxicities and elimination pathways. 
The sheep were injected with 1 ml of the nanoparticle suspension into each carpometaphalangeal joint and 2 
ml into each stifle joint, corresponding to 6 ml nanoparticle suspension or 27.6 mg elemental iron per animal.  
The body weights of the sheep in this study ranged between 45 kg and 81 kg, resulting in a dosage of 0.61 to 
0.34 mg elementary iron per kg body weight.  
Comparing the dosage used in this trial with clinically employed treatment regimens used in veterinary 
practice, such as the recommended dose for prevention of iron deficiency anemia in baby pigs (1-3 days of 
age) is 100- 150 mg of elemental iron IM per pig (Label directions: Ferrextran-100, Fort Dodge). Assuming 
that SPION will be spread throughout the body system on hematologic or lymphatic pathways we did not 
expect that SPION will be detected in the blood as standard blood tests for iron are not sensitive enough to 
detect such small amounts of iron in sheep. Blood samples were taken, but there was no deviation in the iron 
parameter in experimental animals from control animals.  
H.E. stained tissue samples were used for examination of morphology and histopathologic changes in different 
organs. None of the organs showed any evidence of harmful effects of the injected nanoparticle suspension on 
their systemic elimination pathway during the examined time period of 120 hours (5 days).  It can be argued 
that this follow-up period is relatively short to assess systemic toxicity or harming effects. However, since 
toxicity of ferrous solutions usually is an acute incidence if accidentally injected intravenously, five days 
seemed an adequate time for this type of study. If concentrations at the local injections sites were toxic, this 
would have been visible during this follow-up time period. This lack of toxicity was consistent with earlier 
results from our group after intraarticular and periarticular application [9]. Therefore it can be safely assumed 
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for future toxicological studies on SPION that significant toxic reactions to the iron component of PVA-
SPION or Cy3.5-amino-PVA-SPION are not likely. 
Pearl´s Prussian Blue (P.B.) and Turnbulls reaction are used to show different forms of iron in tissues [14].  
P.B. stains iron in the ferric (Fe3+) form and Turnbulls reaction stains iron in the ferrous (Fe2+) form. The 
injected nanoparticles contain ferric and ferrous iron and an earlier study showed that the P.B. and Turnbulls 
reactions are well suited methods for detecting these particles in synoviocytes in monolayer cell cultures [15].  
Hemoglobin and myoglobin contain iron in the Fe2+ form, but cannot be stained by the Turnbull reaction. In 
plasma, ceruloplasmin oxidizes ferrous iron immediately to ferric iron (Fe3+). Therefore, ferrous iron is usually 
found only to a small amount in the body.  Iron is stored in the body in various tissues as either a soluble, 
mobile fraction (ferritin) or as insoluble aggregated deposits (hemosiderin) [16]. Both these forms contain iron 
in the ferric form and hemosiderin is readily stained with the P.B. reaction. Spleen and liver usually have the 
highest storage iron concentrations and the iron found on the P.B. stained specimen is likely storage iron in 
form of hemosiderin.  
Although, iron is present physiologically in different forms and can be found throughout the body, differences 
existed in the sheep after PVA-SPION application. The significant increase in Fe3+ particles found in lymph 
nodes, spleen, liver and kidneys of test animals when compared to controls seems to result that the iron 
injected into the joints of the test animals was incorporated into their physiological iron metabolisms as 
hypothesized. Tracing of the PVA-SPION itself was not possible as none of the components except the iron 
was detectable in vivo. 
The spleen appears to be the organ that had the highest iron storage capacity in sheep. In our scoring system 
the mean score for the spleen was higher than that of the other examined organs and reached the maximum 
score at 120 hours after injection of test animals in both, the Fe3+ and Fe2+ ions.  
Fe3+ ions were not detected in either the liver of control animals or of sheep sacrificed 3 hours after injection, 
however, there was significant increase between 3 and 120 hours post injection indicating a function of the 
sheep liver in iron storage as well. This is not surprising given the physiological role of the liver and the 
spleen. At 3 hours after injection there was also a significant increase of Fe2+ ions in the liver. Histologically 
this is to be interpreted as an increase of non-haem iron in the liver. As reference values are missing for the 
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sheep it can not be stated if the increase is due to the SPION injection, physiological or shows evidence for 
hemochromatosis, but will be proven with MRT in future studies. 
The kidneys are known to have iron storage capacity in other species, which we could confirm for sheep in the 
control group. The immediate increase in Fe3+ concentration after intraarticular PVA-SPION injections, 
however, implies either increased resorption and/or storage of iron in the proximal tubules, but glomerular 
filtration and reabsorption of ferritin (~20,000 Da) in the proximal tubules could be possible too. Therefore it 
can be assumed that SPION are not simply excreted via the kidneys into the urine but dissociation of SPION 
into single components is possible and then iron is entered into the physiologic iron metabolism. The small 
particle size may even allow resorption of the SPION alone or bound to a transport protein, such as albumin. 
Transmission electron microscopy of samples will hopefully clarify these questions in the future (study 
ongoing, senior author). 
The lymph nodes are not an iron storing tissue, but the macrophages as part of the MPS are able to 
phagocytose iron containing particles. The small number of particles seen on lymph node specimen of control 
animals result likely from hematomas and the significant increase in particle concentration at each time after 
injection suggests phagocytosis of PVA-SPION. 
Iron in the ferrous form was found in spleen and liver samples of control animals and in spleen, liver, lymph 
node and kidney samples of test animals. The locations of detected Fe2+ ions were the same as for Fe3+ ions, 
but the quantity was less. Scores similar to those in the Fe3+ evaluation were reached in spleen and liver 
samples only. A clear pattern of particle distribution over the different time frames could not be detected given 
the small sample size per group. However, this observation may lead to speculations that an immediate 
transformation of ferrous iron to ferric iron by enzyme (ceruloplasmin) activity in synovial tissues may have 
occurred before release into lymph or blood circulation. Liver and spleen are known to be important sites of 
iron metabolism, therefore detection of iron particles in different forms (Fe3+/Fe2+) were to be expected. 
It could not be proven whether the Cy3.5 dye kept its covalent binding to the amino-PVA-SPION. Cy3.5 has 
been used to indicate if the binding to the SPION is stable throughout the distribution and elimination process. 
Clear attribution of fluorescent signals to SPION during fluorescence microscopy was not possible. It can be 
assumed that the very low concentration of dye/particle (<10) together with an iron concentration of 0.61 to 
 14 
0.34 mg elementary iron per kg body weight allowed very high distribution and dilution of Cy3.5 throughout 
the body. Within the synovial membrane positive signals of SPION could be proven at any times of evaluation 
[9]. Whether Cy3.5 left the synovial membrane at all could not be proven in this study. In this study Cy3.5 has 
been used to indicate how pharmaceutical products may react if bound to SPION and applied for localized 
treatment of chronic or acute inflammatory joint diseases. We hypothesize that therapeutically interesting dye 
concentrations are only present in the synovial membrane supporting our goal to accumulate the dye in the 
area of interest only. At this stage it can not be assumed that pharmaceutical products, administered at the 
same conditions as Cy3.5, maintain a therapeutic level of activity when removed systemically from the 
synovial membrane. 
 
Conclusion: 
We demonstrated that the distribution and elimination of plain and with Cy3.5 functionalized PVA-SPION 
could be followed in vivo after intraarticular application in sheep. Administration of these nanoparticles was 
safe and the iron component seemed after initial filtration and reabsorption within the proximal tubules of the 
kidney to be incorporated into the physiological iron metabolism, followed by its degradation in the 
reticuloendothelial system. Side effects were absent in all organs tested and therefore, the intraarticular use of 
PVA-SPION is promising as an attractive carriers for future targeted drug delivery in joint disease. Future 
studies with these particles will focus on medical applications in combination with drugs or genetic material 
and on the systemic elimination of the PVA coating from the body. 
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Figure 1. Kidney tissue; a, blue stained iron (Fe3+) in epithelial cells of proximal tubules 24 hours 
post PVA-SPION injection (P.B., 40x); b, distribution of detected iron ions in P.B. stained kidney 
tissue of controls and of animals injected with SPION; c, brown stained iron (Fe2+) in epithelial cells 
of proximal tubules 72 hours post PVA-SPION injection (Turnbull, 40x); d, distribution of detected 
iron ions in Turnbull stained kidney tissue of controls and of animals injected with SPION. 
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Figure 2. Distribution of detected iron ions (Fe3+) in P.B. stained 
lymph node tissue of controls and of animals injected with 
SPION. 
 
 18 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0.8 
0.6 
0.4 
0.2 
0.0 
 M
ea
n 
Sc
or
es
 
Time Post-Injection 
3h 24h 72h 120h control 
4 2,388 ,597 5,232 ,0004 20,928 ,977
439 50,090 ,114
DF Sum of Squares Mean Square F-Value P-Value Lambda Power
Code Time
Residual
ANOVA Table for Lymph nodes
120 0,000 0,000 0,000
42 0,000 0,000 0,000
96 ,177 ,580 ,059
96 0,000 0,000 0,000
90 ,100 ,451 ,048
Count Mean Std. Dev. Std. Err.
000 hours
003 hours
024 hours 
072 hours
120 hours
Means Table for Lymph nodes
Effect: Code Time
0
,1
,2
,3
,4
,5
,6
,7
,8
C
e
ll 
M
e
a
n
0
0
0
 h
o
u
rs
0
0
3
 h
o
u
rs
0
2
4
 h
o
u
rs
 
0
7
2
 h
o
u
rs
1
2
0
 h
o
u
rs
Cell
Interaction Bar Plot for Lymph nodes
Effect: Code Time
Error Bars: ± 1 Standard Deviation(s)
Figure 3. Distribution of detected iron ions (Fe2+) in Turnbull 
stained lymph node tissue of controls and of animals injected with 
SPION. 
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Figure 4. Spleen tissue; a, blue stained macrophages 3 hours post PVA-SPION injection (P.B., 20x); 
b, distribution of detected iron ions (Fe3+) in P.B. stained spleen tissue of controls and of animals 
injected with SPION; c, brown stained macrophages 3 hours post PVA-SPION injection (Turnbull, 
20x); d, distribution of detected iron ions (Fe2+) in Turnbull stained spleen tissue of controls and of 
animals injected with SPION. 
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Figure 5. Liver tissue; a, blue stained Kupffer cells and periportal macrophages 120 hours post PVA-
SPION injection (P.B., 20x); b, distribution of detected iron ions (Fe3+) in P.B. stained liver tissue of 
controls and of animals injected with SPION; c, distribution of detected iron ions (Fe2+) in Turnbull 
stained liver tissue of controls and of animals injected with SPION. 
 
Zusammenfassung: 
PVA umhüllte und fluoreszierend gefärbte (Cy 3.5) funktionalisierte Vinyl Alkohol/ 
Vinyl Amin Copolymer behüllte superparamagnetische Eisenoxid Nanopartikel 
(superparamagnetic iron oxide nanoparticles: SPION) wurden auf systemische 
Verteilung und Elimination nach intraartikulärer Injektion bei Schafen untersucht. 
Die Untersuchungen wurden 3, 24, 72 und 120 Stunden nach der Injektion mittels 
Lichtmikroskop, Fluoreszenzmikroskop und confokalem Mikroskop durchgeführt. 
Dabei konnte kein pathologischer Einfluss der SPION auf die gewonnenen 
Gewebeproben erkannt werden. Signifikant erhöhte Eisengehalte nach SPION- 
Injektion wurden in Nieren, Lymphknoten und Milz beobachtet. Dagegen wurden 
keine Eisenpartikel in Leber, Harnblase und Gallenblase entdeckt. Ein positives 
fluoreszierendes Signal konnte in keinem Organ den SPION zugeordnet werden. 
Unsere Ergebnisse deuten daraufhin, dass der Eisenanteil der SPION im 
Anschluss an eine Rückresorption im proximalen Tubulussystem der Nieren im 
physiologischen Eisenstoffwechsel verarbeitet werden kann, und dass die 
Konzentration des Cy3.5 im Körper zu niedrig war um nachgewiesen werden zu 
können. 
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